CFO
VXRT

Custos Family Office’s Vaxart VXRT Stock Holding History

Custos Family Office’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-50,000
Closed -$18.2K – 68
2025
Q3 		$18.2K Buy
50,000
+40,000
+400% +$16.4K 0.01% 64
2025
Q2 		$4.52K Buy
+10,000
New +$4.35K ﹤0.01% 73

Other funds holding VXRT

HWA
Heritage Wealth Advisors Richmond, Virginia $2.56B AUM 19.48% 1-Year Est. Return
LCM
LVM Capital Management Portage, Michigan $1.19B AUM 41.5% 1-Year Est. Return
KWA
Kingswood Wealth Advisors San Diego, California $2.48B AUM 36.19% 1-Year Est. Return
OP
ORG Partners Roanoke, Indiana $568M AUM 24.16% 1-Year Est. Return
AIC
Archer Investment Corporation Carmel, Indiana $508M AUM 24.79% 1-Year Est. Return

Custos Family Office's VXRT Position: Q4 2025 in Review

Custos Family Office sold out of Vaxart (VXRT) in Q4 2025, closing a stake of 50,000 shares — an estimated $18.2K sold.

Custos Family Office first reported a position in VXRT in Q2 2025 and held it in 2 quarters. The position peaked at $18.2K in Q3 2025. 5 funds tracked by Wall St. Rank hold VXRT as of Q4 2025.

  • Custos Family Office reported no remaining Vaxart position as of Q4 2025 after selling out during the quarter.
  • Custos Family Office sold 50,000 Vaxart shares in Q4 2025, an estimated $18.2K.
  • Custos Family Office first reported a position in Vaxart in Q2 2025 and held it in 2 quarters.
  • Custos Family Office's Vaxart position peaked at $18.2K in Q3 2025.
  • 5 funds tracked by Wall St. Rank held Vaxart as of Q4 2025.

Based on Custos Family Office's 13F filing for Q4 2025, filed 17 Feb 2026.